Search Results - "Paroskie, A."

Laboratory variability in the diagnosis of type 2 VWD variants by DiGiandomenico, Stefanie, Christopherson, Pamela A., Haberichter, Sandra L., Abshire, Thomas C., Montgomery, Robert R., Flood, Veronica H., Valentino, L., Abshire, T., Dunn, A., Bennett, C., Lusher, J., Rajpurkar, M., Hoots, W. K., Brown, D., Shapiro, A., Paola, J. Di, Lentz, S., Gill, J., Leissinger, C., Ragni, M., Hord, J., Manco‐Johnson, M., Ma, A., Boggio, L., Sharathkumar, A., Gruppo, R., Kerlin, B., Journeycake, J., Kulkarni, R., Mahoney, D, Mathias, L., Bedros, A., Diamond, C., Neff, A., Paroskie, A., DiMichele, D., Giardina, P., Cohen, A., Paidas, M., Werner, E., Matsunaga, A., Singer, T., Tarantino, M., Roberts, J., Shafer, F., Konkle, B., Cuker, A., Kouides, P., Stein, D., Manco‐Johnson, M., Dunn, A., Bennett, C., Journeycake, J., Lusher, J., Rajpurkar, M., Shapiro, A., Lentz, S., Lillicrap, D., James, P., Leissinger, C., Roberts, J., Ragni, M.

“…Essentials Patients with von Willebrand disease were enrolled in our study. Type 2 VWD diagnoses were based on original test results. Repeat evaluation…”
Get full text

Haemophilia A carriers experience reduced health-related quality of life by Gilbert, L., Paroskie, A., Gailani, D., Debaun, M. R., Sidonio, R. F.

“…Introduction Haemophilia A is an X‐linked recessive bleeding disorder that primarily affects males. Emerging data support evidence for increased bleeding in…”
Get full text

Radionuclide synovectomy in patients with bleeding disorders: a review of malignancy and myeloproliferative neoplasms from the ATHNdataset by Lim, M. Y., Cheng, D., Aschman, D., Dunn, A., Ahuja, S, Carpenter, SL, Davis, JA, French, J, Gruppo, R, Knoll, C, McGuinn, C, Pipe, SW, Sanders, J, Shapiro, A, Sidonio, R, Soni, A, Stein, DT, Tarantino, MD, Paroskie, A, Young, G

Get full text

Period gene expression in mouse endocrine tissues by Bittman, Eric L, Doherty, Leo, Huang, Liyue, Paroskie, Allison

“…Circadian rhythms are generated by the oscillating expression of the Per1 and Per2 genes, which are expressed not only in the central brain pacemaker but also…”
Get more information

Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A by Giangrande, Paul, Andreeva, Tatiana, Chowdary, Pratima, Ehrenforth, Silke, Hanabusa, Hideji, Leebeek, Frank W G, Lentz, Steven R, Nemes, Laszlo, Poulsen, Lone Hvitfeldt, Santagostino, Elena, You, Chur Woo, Clausen, Wan Hui Ong, Jönsson, Peter G, Oldenburg, Johannes

“…Turoctocog alfa pegol (N8-GP) is a novel glycoPEGylated extended half-life recombinant factor VIII (FVIII) product developed for prophylaxis and treatment of…”
Get more information